cardiovascular disease

Novo’s GLP-1 Wegovy could improve heart health for millions more than previously thought, AI study finds
Pharma Voice
Mon, 10/7/24 - 11:23 am
Novo Nordisk
Wegovy
cardiovascular disease
artificial intelligence
Dandelion Health
J&J to shutter cardiovascular, metabolic drug unit
Seeking Alpha
Thu, 09/26/24 - 03:15 pm
JNJ
layoffs
restructuring
cardiovascular disease
metabolic diseases
Gene therapy biotech Medera looks back to SPAC as way to go public
Fierce Biotech
Thu, 09/5/24 - 11:27 am
Medera
SPACs
gene therapy
cardiovascular disease
Bayer’s kidney disease drug Kerendia reduces cardiovascular risk by 16%
BioSpace
Tue, 09/3/24 - 11:31 am
Bayer
Kerendia
cardiovascular disease
heart failure
clinical trials
Novo builds heart failure case for semaglutide
BioPharma Dive
Fri, 08/30/24 - 11:31 am
Novo Nordisk
obesity
semaglutide
cardiovascular disease
Medicare Coverage of Novo’s Semaglutide for CVD Could Cost $145B Annually: Study
BioSpace
Tue, 08/27/24 - 11:32 am
Novo Nordisk
cardiovascular disease
Medicare
semaglutide
Wegovy
Ozempic
Arrowhead axes heart disease drug, goes all in on another as pipeline progress drives costs up
Fierce Biotech
Wed, 06/26/24 - 10:05 am
Arrowhead Pharmaceuticals
RNAi
zodasiran
plozasiran
cardiovascular disease
Statins for heart disease prevention could be recommended for far fewer Americans if new risk equation is adopted
Medical Xpress
Wed, 06/12/24 - 11:15 am
statins
cholesterol
cardiovascular disease
Boehringer pays OSE $42M to expand collab into cardio disease, grab new asset
Fierce Biotech
Wed, 05/22/24 - 11:31 am
Boehringer Ingelheim
OSE Immunotherapeutics
cardiovascular disease
solid tumors
BMS, Avidity add another link to cardiovascular partnership with $100M expansion
Fierce Biotech
Tue, 11/28/23 - 10:29 am
Bristol Myers Squibb
Avidity Biosciences
R&D
cardiovascular disease
Novo Nordisk says Wegovy can help heart disease patients—and not just because it produces weight loss
Fierce Pharma
Mon, 11/13/23 - 12:08 pm
Novo Nordisk
Wegovy
heart disease
cardiovascular disease
clinical trials
AHA: One dose of Lilly’s siRNA drug cuts Lp(a) for a year
Pharmaphorum
Mon, 11/13/23 - 10:03 am
Eli Lilly
AHA
siRNA
lipoprotein(a)
cardiovascular disease
lepodisiran
Wegovy cuts risk of heart attacks in milestone cardiovascular trial
Stat
Sun, 11/12/23 - 09:32 pm
Wegovy
Novo Nordisk
clinical trials
cardiovascular disease
Merck keeps pumping up sotatercept, posting fresh data ahead of FDA approval ruling
Fierce Biotech
Mon, 09/11/23 - 12:35 pm
Merck
sotatercept
FDA
cardiovascular disease
Wegovy costs $1.1m to prevent one heart attack, stroke, or cardiovascular death
Airfinity
Thu, 08/31/23 - 11:52 am
Novo Nordisk
Wegovy
Ozempic
cardiovascular disease
Amgen Presents Late-Breaking Phase 2 Olpasiran Data at ESC 2023
BioSpace
Mon, 08/28/23 - 12:02 pm
Amgen
cardiovascular disease
olpasiran
clinical trials
Merck bets big on oral PCSK9 inhibitor, putting 6-year outcome study at heart of phase 3 program
Fierce Biotech
Fri, 08/25/23 - 09:57 am
Merck
PCSK9 inhibitors
clinical trials
cardiovascular disease
cholesterol
MK-0616
3 Massive New Markets Could Await Ozempic, And They Might Make Novo Nordisk Investors Richer
Motley Fool
Thu, 08/24/23 - 09:50 pm
Novo Nordisk
Ozempic
diabetes
weight loss
liver disease
addiction
cardiovascular disease
Novo Nordisk posts 'best-case scenario' cardio outcomes data for star obesity drug Wegovy
Fierce Pharma
Tue, 08/8/23 - 11:25 am
Novo Nordisk
Wegovy
clinical trials
cardiovascular disease
obesity
Statins reduce cardiovascular risk in people living with HIV, new global study finds
Stat
Mon, 07/24/23 - 09:58 am
statins
HIV
cardiovascular disease

Pages